These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12351293)

  • 1. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow.
    Prielipp RC; Wall MH; Tobin JR; Groban L; Cannon MA; Fahey FH; Gage HD; Stump DA; James RL; Bennett J; Butterworth J
    Anesth Analg; 2002 Oct; 95(4):1052-9, table of contents. PubMed ID: 12351293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers.
    Prielipp RC; Wall MH; Groban L; Tobin JR; Fahey FH; Harkness BA; Stump DA; James RL; Cannon MA; Bennett J; Butterworth J
    Anesth Analg; 2001 Jul; 93(1):45-52. PubMed ID: 11429337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular dexmedetomidine decreases cerebral blood flow during normoxia and hypoxia in dogs.
    McPherson RW; Koehler RC; Kirsch JR; Traystman RJ
    Anesth Analg; 1997 Jan; 84(1):139-47. PubMed ID: 8989015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of dexmedetomidine on intracranial hemodynamics in severe head injured patients].
    Grille P; Biestro A; Fariña G; Miraballes R
    Neurocirugia (Astur); 2005 Oct; 16(5):411-8. PubMed ID: 16276449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dexmedetomidine on cerebral blood flow in critically ill patients with or without traumatic brain injury: a prospective controlled trial.
    Wang X; Ji J; Fen L; Wang A
    Brain Inj; 2013; 27(13-14):1617-22. PubMed ID: 24102571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of dexmedetomidine sedation in children.
    Wong J; Steil GM; Curtis M; Papas A; Zurakowski D; Mason KP
    Anesth Analg; 2012 Jan; 114(1):193-9. PubMed ID: 21965374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thigh cuff method.
    Ogawa Y; Iwasaki K; Aoki K; Kojima W; Kato J; Ogawa S
    Anesthesiology; 2008 Oct; 109(4):642-50. PubMed ID: 18813043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.
    Zornow MH; Fleischer JE; Scheller MS; Nakakimura K; Drummond JC
    Anesth Analg; 1990 Jun; 70(6):624-30. PubMed ID: 1971500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions.
    Hall JE; Uhrich TD; Barney JA; Arain SR; Ebert TJ
    Anesth Analg; 2000 Mar; 90(3):699-705. PubMed ID: 10702460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine decreases the oral mucosal blood flow.
    Kawaai H; Yoshida K; Tanaka E; Togami K; Tada H; Ganzberg S; Yamazaki S
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):928-31. PubMed ID: 23958351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of dexmedetomidine on laser-Doppler flow and pial arteriolar diameter.
    Ganjoo P; Farber NE; Hudetz A; Smith JJ; Samso E; Kampine JP; Schmeling WT
    Anesthesiology; 1998 Feb; 88(2):429-39. PubMed ID: 9477064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexmedetomidine infusion during spinal anesthesia on hemodynamics and sedation.
    Tarıkçı Kılıç E; Aydın G
    Libyan J Med; 2018 Dec; 13(1):1436845. PubMed ID: 29457538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine decreases cerebral blood flow velocity in humans.
    Zornow MH; Maze M; Dyck JB; Shafer SL
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):350-3. PubMed ID: 8094720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain tissue oxygenation during dexmedetomidine administration in surgical patients with neurovascular injuries.
    Drummond JC; Sturaitis MK
    J Neurosurg Anesthesiol; 2010 Oct; 22(4):336-41. PubMed ID: 20622684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia, alpha 2-adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow.
    McPherson RW; Koehler RC; Traystman RJ
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H476-82. PubMed ID: 7511347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects.
    Shehabi Y; Ruettimann U; Adamson H; Innes R; Ickeringill M
    Intensive Care Med; 2004 Dec; 30(12):2188-96. PubMed ID: 15338124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of alpha(2) agonist-induced sedation and its reversal with an alpha(2) antagonist on organ blood flow in sheep.
    Talke PO; Traber DL; Richardson CA; Harper DD; Traber LD
    Anesth Analg; 2000 May; 90(5):1060-6. PubMed ID: 10781453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats.
    Nakano T; Okamoto H
    J Anesth; 2009; 23(3):378-84. PubMed ID: 19685118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dexmedetomidine on nutrient organ blood flow.
    Lawrence CJ; Prinzen FW; de Lange S
    Anesth Analg; 1996 Dec; 83(6):1160-5. PubMed ID: 8942579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment.
    De Wolf AM; Fragen RJ; Avram MJ; Fitzgerald PC; Rahimi-Danesh F
    Anesth Analg; 2001 Nov; 93(5):1205-9. PubMed ID: 11682398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.